Paul L. Berns

Insider Reports History

Entity: Individual
Location: 11080 Circlepoint Rd., Ste, 200, Westminster, CO
Signature: /s/ Michael Milligan, as Attorney-in-Fact for Paul L. Berns
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul L. Berns:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Neumora Therapeutics, Inc.	Title: Chief Executive Officer and Chairman of the Board, Director	Common Stock	7.41M	$12.5M	$1.69	Feb 18, 2025	Direct
Jazz Pharmaceuticals plc	Director	Ordinary Shares	8.29K	$988K	$119.13	Aug 5, 2021	Direct
Neumora Therapeutics, Inc.	Title: Chief Executive Officer and Chairman of the Board, Director	Common Stock	133K	$225K	$1.69	Feb 18, 2025	Indirect
Unity Biotechnology, Inc.	Director	Stock Option (Right to Buy)	10K	$27.7K	$2.77	Jun 21, 2024	Direct
Metsera, Inc.	Director	Common Stock	8.31M			Feb 3, 2025	Indirect
Metsera, Inc.	Director	Common Stock	958K			Feb 3, 2025	Direct
Neumora Therapeutics, Inc.	Title: Chief Executive Officer and Chairman of the Board, Director	Stock Option (Right to Buy)	343K			Feb 13, 2025	Direct
EQRx, Inc.	Director	Common Stock	0		$2.21	Nov 9, 2023	Direct
EQRx, Inc.	Director	Earn-out Shares	0			Nov 9, 2023	Direct
EQRx, Inc.	Director	Stock Option (Right to Buy)	0			Nov 9, 2023	Direct
Metsera, Inc.	Director	Series A Convertible Preferred Stock	0			Feb 3, 2025	Indirect
Metsera, Inc.	Director	Series B Convertible Preferred Stock	0			Feb 3, 2025	Indirect

Showing 1 to 12 of 12 entries

Insider Reports Filed by Paul L. Berns

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
NMRA	Neumora Therapeutics, Inc.	Feb 18, 2025	1	-$23.5K	4	Feb 20, 2025	Title: Chief Executive Officer and Chairman of the Board, Director
NMRA	Neumora Therapeutics, Inc.	Feb 13, 2025	7	$0	4	Feb 18, 2025	Title: Chief Executive Officer and Chairman of the Board, Director
MTSR	Metsera, Inc.	Feb 3, 2025	4	$14.2M	4	Feb 3, 2025	Director
MTSR	Metsera, Inc.	Jan 30, 2025	0	$0	3	Jan 30, 2025	Director, 10%+ Owner
NMRA	Neumora Therapeutics, Inc.	Dec 27, 2024	3	$0	4	Dec 27, 2024	Director
UBX	Unity Biotechnology, Inc.	Jun 21, 2024	1	$0	4	Jun 21, 2024	Director
NMRA	Neumora Therapeutics, Inc.	Feb 14, 2024	2	$0	4	Feb 16, 2024	Director
EQRX	EQRx, Inc.	Nov 9, 2023	3	$0	4	Nov 9, 2023	Director
NMRA	Neumora Therapeutics, Inc.	Sep 14, 2023	0	$0	3	Sep 14, 2023	Director
UBX	Unity Biotechnology, Inc.	Jun 23, 2023	1	$0	4	Jun 26, 2023	Director
EQRX	EQRx, Inc.	Jan 1, 2023	1	$0	4	Jan 4, 2023	Director
EQRX	EQRx, Inc.	Sep 30, 2022	1	$0	4	Oct 4, 2022	Director
UBX	Unity Biotechnology, Inc.	Jun 24, 2022	1	$0	4	Jun 27, 2022	Director
EQRX	EQRx, Inc.	Dec 17, 2021	2	$0	4	Dec 21, 2021	Director
EQRX	EQRx, Inc.	Dec 17, 2021	0	$0	3	Dec 20, 2021	Director
JAZZ	Jazz Pharmaceuticals plc	Aug 5, 2021	1	-$223K	4	Aug 9, 2021	Director
UBX	Unity Biotechnology, Inc.	Jun 24, 2021	1	$0	4	Jun 28, 2021	Director